MoneyWorks4Me

Venus Remedies informs about press release

20 Sep 2023 Evaluate

Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies extends Its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..